Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.
Claire Bar, Giulia Barcia, Mélanie Jennesson, Gwenaël Le Guyader, Amy Schneider, Cyril Mignot, Gaetan Lesca, Delphine Breuillard, Martino Montomoli, Boris Keren, Diane Doummar, Thierry Billette de Villemeur, Alexandra Afenjar, Isabelle Marey, Marion Gerard, Hervé Isnard, Alice Poisson, Sophie Dupont, Patrick Berquin, Pierre Meyer, David Genevieve, Anne De Saint Martin, Salima El Chehadeh, Jamel Chelly, Agnès Guët, Emmanuel Scalais, Nathalie Dorison, Candace T Myers, Heather C Mefford, Katherine B Howell, Carla Marini, Jeremy L Freeman, Anca Nica, Gaetano Terrone, Tayeb Sekhara, Anne-Sophie Lebre, Sylvie Odent, Lynette G Sadleir, Arnold Munnich, Renzo Guerrini, Ingrid E Scheffer, Edor Kabashi, Rima Nabbout
Journal: Human mutation
2021;41(1):69-80
PMID: 31513310
Abstract
Developmental and epileptic encephalopathies (DEE) refer to a heterogeneous group of devastating neurodevelopmental disorders. Variants in KCNB1 have been recently reported in patients with early-onset DEE. KCNB1 encodes the α subunit of the delayed rectifier voltage-dependent potassium channel K 2.1. We review the 37 previously reported patients carrying 29 distinct KCNB1 variants and significantly expand the mutational spectrum describing 18 novel variants from 27 unreported patients. Most variants occur de novo and mainly consist of missense variants located on the voltage sensor and the pore domain of K 2.1. We also report the first inherited variant (p.Arg583*). KCNB1-related encephalopathies encompass a wide spectrum of neurodevelopmental disorders with predominant language difficulties and behavioral impairment. Eighty-five percent of patients developed epilepsies with variable syndromes and prognosis. Truncating variants in the C-terminal domain are associated with a less-severe epileptic phenotype. Overall, this report provides an up-to-date review of the mutational and clinical spectrum of KCNB1, strengthening its place as a causal gene in DEEs and emphasizing the need for further functional studies to unravel the underlying mechanisms.
© 2019 Wiley Periodicals, Inc.
Address:
Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Hôpital Necker-Enfants Malades, Paris, France.; Imagine institute, laboratory of Translational Research for Neurological Disorders, INSERM UMR 1163, Imagine Institute, Paris, France.; Université Paris Descartes-Sorbonne Paris Cité, Paris, France.; Imagine institute, laboratory of Translational Research for Neurological Disorders, INSERM UMR 1163, Imagine Institute, Paris, France.; Université Paris Descartes-Sorbonne Paris Cité, Paris, France.; Department of genetics, Necker Enfants Malades hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Department of Pediatrics, American Memorial Hospital, Reims, France.; Department of genetics, University hospital Poitiers, Poitiers Cedex, France.; EA3808-NEUVACOD Unité Neurovasculaire et Troubles Cognitifs, Pôle Biologie Santé, Université de Poitiers, Poitiers, France.; Department of Medicine, Epilepsy Research Centre, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.; Institut du Cerveau et de la Moelle épinière, INSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Paris, France.; Département de Génétique et de Cytogénétique, Centre de Reference Déficience Intellectuelle de Causes Rares, APHP, Hôpital Pitié-Salpêtrière, GRC UPMC (Déficience Intellectuelle et Autisme), Paris, France.; Department of genetics, Hospices Civils de Lyon, Lyon, France.; Neurosciences centre of Lyon, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Bron Cedex, France.; Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Hôpital Necker-Enfants Malades, Paris, France.; Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Department of Neuroscience, A Meyer Children's Hospital, University of Florence, Florence, Italy.; Département de Génétique et de Cytogénétique, Centre de Reference Déficience Intellectuelle de Causes Rares, APHP, Hôpital Pitié-Salpêtrière, GRC UPMC (Déficience Intellectuelle et Autisme), Paris, France.; Department of Pediatric Neurology, Hôpital Armand Trousseau, AP-HP, Paris, France.; Département de Génétique et Embryologie Médicale, Pathologies Congénitales du Cervelet-LeucoDystrophies, Centre de Référence déficiences intellectuelles de causes rares, AP-HP, Hôpital Armand Trousseau, GRC n°19, Sorbonne Université, Paris, France.; Department of genetics, CHU Côte de Nacre, Caen, France.; Neurology clinic, Lyon, France.; Reference Center for Diagnosis and Management of Genetic Psychiatric Disorders, Centre Hospitalier le Vinatier and EDR-Psy Team, Centre National de la Recherche Scientifique & Lyon 1 Claude Bernard University, Villeurbanne, France.; Institut du Cerveau et de la Moelle épinière, INSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Paris, France.; Epileptology and Rehabilitation department, GH Pitie-Salpêtrière-Charles Foix, AP-HP, Paris, France.; Department of pediatric neurology Amiens-Picardie university hospital, Université de Picardie Jules Verne, Amiens, France.; Department of pediatric neurology, Montpellier university hospital, Montpellier, France.; PhyMedExp, U1046 INSERM, UMR9214 CNRS, Montpellier, France.; Service de génétique clinique et du Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de référence maladies rares anomalies du développement, CHU Montpellier, Montpellier, France.; Department of Pediatric Neurology, Strasbourg University Hospital, Strasbourg, France.; Department of genetics, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Department of Pediatric, Louis-Mourier Hospital, Colombes, France.; Department of Pediatric Neurology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg City, Luxembourg.; Department of pediatric Neurosurgery, Rothschild Foundation Hospital, Paris, France.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington.; Departments of Neurology and Paediatrics, Royal Children's Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Neurology, Center for Clinical Research (CIC 1414), Rennes University Hospital, Rennes, France.; Department of Translational Medical Sciences, Section of Pediatrics-Child Neurology Unit, Federico II University, Naples, Italy.; Department of Pediatric Neurology, C.H.I.R.E.C, Brussels, Belgium.; Department of genetics, Maison Blanche hospital, University hospital, Reims, Reims, France.; Reference Centre for Rare Developmental Abnormalities, CLAD-Ouest, CHU Rennes, Rennes, France.; Institute of genetics and development, CNRS UMR 6290, Rennes university, Rennes, France.; Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.; Université Paris Descartes-Sorbonne Paris Cité, Paris, France.; Department of genetics, Necker Enfants Malades hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Department of Medicine, Epilepsy Research Centre, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.; Departments of Neurology and Paediatrics, Royal Children's Hospital, University of Melbourne, Melbourne, Victoria, Australia.; The Florey Institute of Neurosciences and Mental Health, Heidelberg, Victoria, Australia.; Imagine institute, laboratory of Translational Research for Neurological Disorders, INSERM UMR 1163, Imagine Institute, Paris, France.; Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
Link outs
Free resources
Full Text Sources:
Medical:
Subscription / membership required
Full Text Sources:
Other Literature Sources:
MeSH Terms:
Alleles,
Epilepsy,
Genetic Association Studies,
Genetic Predisposition to Disease,
Genetic Variation,
Genotype,
Humans,
Neurodevelopmental Disorders,
Phenotype,
Shab Potassium Channels,
Structure-Activity Relationship